Zurcher Kantonalbank Zurich Cantonalbank lowered its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Rating) by 11.1% during the second quarter, Holdings Channel reports. The institutional investor owned 16,734 shares of the biopharmaceutical company’s stock after selling 2,085 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Halozyme Therapeutics were worth $736,000 […]